Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off.

Source:http://linkedlifedata.com/resource/pubmed/id/10788044

Fortune 2000 Jan 10 141 1 132-4, 135

Download in:

View as

General Info

PMID
10788044